FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086245480> ?p ?o ?g. }

• W2086245480 endingPage "357" @default.
• W2086245480 startingPage "351" @default.
• W2086245480 abstract "To determine whether the combination of vorinostat (suberoylanilide hydroxamic acid, SAHA) and paclitaxel is more effective than either individual agent and to evaluate the effect of drug sequencing in ovarian cancer cell lines and in mouse models.For in vitro studies, three ovarian cancer cell lines (2774, SKOV-3 and OVCAR-3) were grown with either 10 nM paclitaxel, or vorinostat (0.3, 1, 3 or 10 μM), or vehicle (DMSO) and subsequently treated with 10 nM paclitaxel, or vorinostat (0.3, 1, 3, or 10 μM), or DMSO. Apoptosis was analyzed. In the mouse, treatments were given for a total of 5 weeks: vehicle control, paclitaxel, vorinostat, vorinostat followed by paclitaxel, paclitaxel followed by vorinostat, and simultaneous vorinostat and paclitaxel. Endpoints were survival, ascites and tumor weight. Protein expression was analyzed by Western blots.In two cell lines (SKOV-3, OVCAR-3), the sequence of vorinostat and paclitaxel administration did not significantly alter the apoptosis percentages and the combination was not superior to individual agents. However, in one cell line (2774), the most effective combination in achieving apoptosis was paclitaxel followed by low dose vorinostat. In the mouse model, both control and vorinostat alone treatment groups were inferior to paclitaxel and the combination treatment groups, but no significant differences were observed between the groups receiving both paclitaxel and vorinostat based on the sequence of administration.The efficacy of the combination and sequence of vorinostat and paclitaxel administration was cell line dependent and suggests that responses vary based on tumor specific characteristics." @default.
• W2086245480 created "2016-06-24" @default.
• W2086245480 creator A5002041109 @default.
• W2086245480 creator A5024756890 @default.
• W2086245480 date "2010-11-01" @default.
• W2086245480 modified "2023-09-24" @default.
• W2086245480 title "In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: Does timing matter?" @default.
• W2086245480 cites W1504303645 @default.
• W2086245480 cites W1899454014 @default.
• W2086245480 cites W1971621147 @default.
• W2086245480 cites W1973666076 @default.
• W2086245480 cites W1978835020 @default.
• W2086245480 cites W1980752656 @default.
• W2086245480 cites W1983587751 @default.
• W2086245480 cites W1996066317 @default.
• W2086245480 cites W2006866162 @default.
• W2086245480 cites W2022285476 @default.
• W2086245480 cites W2022415712 @default.
• W2086245480 cites W2027741880 @default.
• W2086245480 cites W2070437897 @default.
• W2086245480 cites W2088783750 @default.
• W2086245480 cites W2097105130 @default.
• W2086245480 cites W2099440961 @default.
• W2086245480 cites W2101995865 @default.
• W2086245480 cites W2102371219 @default.
• W2086245480 cites W2110362707 @default.
• W2086245480 cites W2113452945 @default.
• W2086245480 cites W2132440338 @default.
• W2086245480 cites W2135085078 @default.
• W2086245480 cites W2159648717 @default.
• W2086245480 cites W2318410985 @default.
• W2086245480 doi "https://doi.org/10.1016/j.ygyno.2010.06.030" @default.
• W2086245480 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20673975" @default.
• W2086245480 hasPublicationYear "2010" @default.
• W2086245480 type Work @default.
• W2086245480 sameAs 2086245480 @default.
• W2086245480 citedByCount "24" @default.
• W2086245480 countsByYear W20862454802012 @default.
• W2086245480 countsByYear W20862454802013 @default.
• W2086245480 countsByYear W20862454802014 @default.
• W2086245480 countsByYear W20862454802015 @default.
• W2086245480 countsByYear W20862454802016 @default.
• W2086245480 countsByYear W20862454802017 @default.
• W2086245480 countsByYear W20862454802019 @default.
• W2086245480 countsByYear W20862454802020 @default.
• W2086245480 countsByYear W20862454802021 @default.
• W2086245480 crossrefType "journal-article" @default.
• W2086245480 hasAuthorship W2086245480A5002041109 @default.
• W2086245480 hasAuthorship W2086245480A5024756890 @default.
• W2086245480 hasConcept C104317684 @default.
• W2086245480 hasConcept C121608353 @default.
• W2086245480 hasConcept C126322002 @default.
• W2086245480 hasConcept C150903083 @default.
• W2086245480 hasConcept C207001950 @default.
• W2086245480 hasConcept C2776202225 @default.
• W2086245480 hasConcept C2776262904 @default.
• W2086245480 hasConcept C2776694085 @default.
• W2086245480 hasConcept C2776999253 @default.
• W2086245480 hasConcept C2777292972 @default.
• W2086245480 hasConcept C2778305200 @default.
• W2086245480 hasConcept C2780427987 @default.
• W2086245480 hasConcept C502942594 @default.
• W2086245480 hasConcept C55493867 @default.
• W2086245480 hasConcept C64927066 @default.
• W2086245480 hasConcept C71924100 @default.
• W2086245480 hasConcept C86803240 @default.
• W2086245480 hasConcept C98274493 @default.
• W2086245480 hasConceptScore W2086245480C104317684 @default.
• W2086245480 hasConceptScore W2086245480C121608353 @default.
• W2086245480 hasConceptScore W2086245480C126322002 @default.
• W2086245480 hasConceptScore W2086245480C150903083 @default.
• W2086245480 hasConceptScore W2086245480C207001950 @default.
• W2086245480 hasConceptScore W2086245480C2776202225 @default.
• W2086245480 hasConceptScore W2086245480C2776262904 @default.
• W2086245480 hasConceptScore W2086245480C2776694085 @default.
• W2086245480 hasConceptScore W2086245480C2776999253 @default.
• W2086245480 hasConceptScore W2086245480C2777292972 @default.
• W2086245480 hasConceptScore W2086245480C2778305200 @default.
• W2086245480 hasConceptScore W2086245480C2780427987 @default.
• W2086245480 hasConceptScore W2086245480C502942594 @default.
• W2086245480 hasConceptScore W2086245480C55493867 @default.
• W2086245480 hasConceptScore W2086245480C64927066 @default.
• W2086245480 hasConceptScore W2086245480C71924100 @default.
• W2086245480 hasConceptScore W2086245480C86803240 @default.
• W2086245480 hasConceptScore W2086245480C98274493 @default.
• W2086245480 hasIssue "2" @default.
• W2086245480 hasLocation W20862454801 @default.
• W2086245480 hasLocation W20862454802 @default.
• W2086245480 hasOpenAccess W2086245480 @default.
• W2086245480 hasPrimaryLocation W20862454801 @default.
• W2086245480 hasRelatedWork W1637594623 @default.
• W2086245480 hasRelatedWork W1899454014 @default.
• W2086245480 hasRelatedWork W2027321070 @default.
• W2086245480 hasRelatedWork W2086245480 @default.
• W2086245480 hasRelatedWork W2738786074 @default.
• W2086245480 hasRelatedWork W2740863466 @default.
• W2086245480 hasRelatedWork W2762969957 @default.
• W2086245480 hasRelatedWork W2955516014 @default.

• next